Top vendors for Cardiology, compared

Six vendors listed in the cardiology category — what they actually make, how directly each connects to cardiac care, and what that means for your procurement decision.

Most vendors in this category serve adjacent or overlapping clinical areas rather than pure cardiology — and knowing that upfront saves significant evaluation time. CytoSorbents, Inc. is the clearest match for cardiac procurement: its CytoSorb 300® extracorporeal adsorber is used during cardiovascular surgery and cardiac ICU care to remove cytokines, drugs, and inflammatory mediators from blood. Grifols Therapeutics LLC lands on cardiac supply chains from a different angle — as a manufacturer of human albumin and coagulation factors, both standard consumables in cardiac surgery programs.

The other four vendors sit further from cardiology. MagVenture A/S has built TMS and magnetic nerve stimulation systems since 1992, with FDA clearance for Major Depressive Disorder — a psychiatry purchase, not cardiac. Radialogica LLC provides radiation oncology QA software and clinical trial services. ION BEAM APPLICATIONS S.A. designs proton therapy systems and dosimetry tools for cancer treatment. Uptake Medical Technology Inc. makes the InterVapor® bronchoscopic vapor ablation system for severe emphysema — a pulmonology device that often coexists with cardiac comorbidities but is procured by thoracic or pulmonology departments.

At a glance

Vendor	Primary specialty	Cardiology relevance	Product type	Founded
CytoSorbents, Inc.	Critical care / cardiovascular	High — CytoSorb used in cardiac surgery and cardiac ICU	Extracorporeal device	2012
Grifols Therapeutics LLC	Plasma-derived biologics	Moderate — albumin and coagulation factors in cardiac surgery formularies	Biological therapeutics	1909
MagVenture A/S	Neurology / psychiatry	Low — FDA-cleared TMS for MDD, not cardiac	Medical device	1992
Radialogica LLC	Radiation oncology QA	None noted	Software / services	2011
ION BEAM APPLICATIONS S.A.	Proton therapy / dosimetry	None noted	Capital hardware + software	1985
Uptake Medical Technology Inc.	Pulmonology	Low — emphysema device adjacent to cardiac comorbidities	Medical device	2005

How they compare

Direct cardiac applications

CytoSorbents is the only vendor here with a product explicitly positioned for cardiovascular use. CytoSorb 300® functions as an extracorporeal adsorber during or following cardiac surgery — it sits in the perfusion circuit and is designed to reduce cytokine load, anesthetic concentrations, and antibiotic levels during procedures involving cardiopulmonary bypass. The company also offers the PuriFi standalone platform for independent CytoSorb therapy and the ECOS-300 device. Cardiac ICU and perfusion teams evaluating adjunctive blood purification should assess this vendor first.

Grifols Therapeutics — operating as Grifols Egypt for Plasma Derivatives, a public-private joint venture — manufactures immunoglobulins, human albumin, and coagulation factors. Albumin is routinely used to prime cardiopulmonary bypass circuits, and coagulation factors are standard tools for managing surgical bleeding in open-heart cases. That said, this entity is Egypt-based; procurement teams should verify current supply chain routing, import approvals, and whether the specific Grifols entity they engage holds the regulatory clearances valid in their jurisdiction before adding it to an approved vendor list.

Adjacent specialties and non-cardiac products

MagVenture's TMS systems hold FDA clearance for MDD treatment in adults and adolescents (the company notes clearance for both populations), backed by over 30 years of manufacturing in Denmark. This is a legitimate behavioral health capital purchase — but it belongs in a psychiatry or integrated behavioral health evaluation, not cardiology.

IBA and Radialogica both serve radiation oncology. IBA's proton therapy systems are capital-intensive installations requiring facility construction and long-term service contracts; Radialogica's software addresses QA compliance and clinical trial program management in the same specialty. Neither company's vendor data indicates cardiology applications. Uptake Medical's InterVapor® system is a non-surgical emphysema treatment delivered via bronchoscope — the procurement decision sits in pulmonology or thoracic surgery even when patients carry concurrent heart disease.

Organizational track record and scale

Longevity matters when you're evaluating service infrastructure and parts availability on capital equipment. IBA (founded 1985) and Grifols (founded 1909) have the longest institutional histories. MagVenture, in operation since 1992, has more than three decades of TMS manufacturing experience and distributes through subsidiaries in the US, UK, Germany, Brazil, and China. CytoSorbents (founded 2012) is the youngest vendor by a margin but has active CE Mark and FDA-cleared products in a growing critical care market. Uptake Medical (2005) and Radialogica (2011) are smaller, more specialized firms. None of these vendors publish service contract or list pricing publicly — verified pricing will require direct RFQ.

How to choose

Match your actual clinical program to the right vendor — most of these won't apply to a pure cardiology buy:

• Cardiac surgery or cardiac ICU perfusion programs: Evaluate CytoSorbents, Inc. for hemoadsorption — specifically CytoSorb 300® and the PuriFi platform for standalone use.
• Cardiac surgery blood bank or pharmacy formulary: Grifols Therapeutics LLC is worth reviewing for albumin and coagulation factor sourcing, pending verification of regulatory status in your jurisdiction.
• Behavioral health or integrated psychiatry programs: MagVenture A/S is the vendor to assess for FDA-cleared TMS in MDD treatment.
• Radiation oncology capital planning: Evaluate ION BEAM APPLICATIONS S.A. for proton therapy infrastructure and Radialogica LLC